going from mounjaro to retatrutide ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Mounjaro And Retatrutide

As we shared in our Q1 earnings date, this solution continues to perform as expected and is projected to generate over $100 million in revenue by 2025

And in addition to causing your pancreas to release insulin, GLP-1 agonists also blocks a hormone that causes your liver to release sugar (glucagon)

2

Our team of compassionate, patient-centered experts is here to support you each step of the way as you work to achieve a balanced life in all areasphysical, emotional, and beyond

Triplitt C, Chiquette E

For a plain explanation of why supplement style products are held to a different standard than approved drugs, see the United States Food and Drug Administration consumer guidance on dietary supplements, which explains why supplement style products are not tested for effectiveness before they are allowed to reach the market